Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Neutrophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.885
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Organ Weight / Spleen weight
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Organ Weight / Spleen weight
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.940
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
5.80×10-05
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Platelet count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0739
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.563
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Monocyte differential count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.686
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.247
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Monocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.214
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.802
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.141
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.661
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.360
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Monocyte cell count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.881
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Eosinophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.555
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0487
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.547
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.510
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Eosinophil differential count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.164
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean platelet volume
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.300
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.745
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000175
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
10f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0892
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.436
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00753
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.701
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.546
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.547
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00203
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.412
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
8.60×10-06
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Eosinophil cell count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00677
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.597
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean cell volume
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.948
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0830
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / cDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0321
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HOM
|
10f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.306
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Hemoglobin
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.886
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Basophil differential count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.583
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00106
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.607
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.744
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Basophil cell count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.562
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / B1B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.105
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000805
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HOM
|
10f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0610
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Red blood cell count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.505
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
10f:9m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0243
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000154
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.293
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HOM
|
10f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.163
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Hematocrit
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.612
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.846
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / B2B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.633
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
9.11×10-05
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0998
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Neutrophil differential count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0589
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0932
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Red blood cell distribution width
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00364
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HOM
|
10f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0579
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.876
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.932
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0267
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000913
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Neutrophil cell count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.253
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00587
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / T Subset
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
2.40×10-09
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.521
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.940
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
2.50×10-07
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0921
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Lymphocyte cell count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
1.85×10-05
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Clinical Chemistry / Glycosilated hemoglobin A1c (HbA1c)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.778
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.193
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
8.44×10-05
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.194
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Lymphocyte differential count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.508
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.619
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000232
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.230
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HOM
|
10f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0194
|
Successful |
Ube3ctm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / White blood cell count
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
8.11×10-06
|
Successful |